Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Omar Kahaly

Clinical Cardiac Electrophysiology Toledo, OH Medical Doctor

NPI 1124394564 CMS profile 537663

2940 N McCord Rd, Toledo, OH 43615

Open in the dashboard

General payments

$26,470

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$53,685 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Omar Kahaly of Toledo, OH is reported in the CMS Open Payments database as having received $26,470 across 142 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $53,685 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 59th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,167 53
2024 General $2,636 21
2023 General $2,750 23
2022 General $837 15
2021 General $651 8
2020 General $680 10
2019 General $12,749 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Omar Kahaly
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Omar Kahaly were reported at $6,167. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Omar Kahaly Clinical Cardiac Electrophysiology median Middle half National median
2019 $12,749 $2,361 $585–$8,260 $163
2020 $680 $993 $247–$4,351 $114
2021 $651 $1,185 $326–$4,739 $132
2022 $837 $2,073 $554–$6,789 $149
2023 $2,750 $2,568 $759–$8,159 $160
2024 $2,636 $2,557 $703–$7,403 $164
2025 $6,167 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $9,424 41 payments
  2. Medtronic Vascular, Inc. $6,433 3 payments
  3. Abbott Laboratories $4,011 30 payments
  4. Medtronic, Inc. $3,511 25 payments
  5. Biotronik Inc. $1,417 12 payments
  6. Biosense Webster, Inc. $722 18 payments
  7. Atricure, Inc. $326 2 payments
  8. Cardiva Medical, Inc. $200 5 payments
  9. Acutus Medical, Inc. $156 1 payment
  10. Aziyo Biologics, Inc. $111 1 payment
  11. Other $159 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $11,503 4 payments
  2. Food and Beverage $8,126 107 payments
  3. Travel and Lodging $6,792 30 payments
  4. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. GENERAL BRADY $4,352 2 payments
  2. AVEIR Cardiac Rhythm Management $2,170 13 payments
  3. General Therapies $1,174 6 payments
  4. AVEIR Structural Heart $1,106 8 payments
  5. General Tachy $901 1 payment
  6. Carto 3 $656 17 payments
  7. SYNERGY ABLATION SYSTEM $326 2 payments
  8. Acticor 7 VR-T DX $285 3 payments
  9. Micra $269 4 payments
  10. COBALT DR MRI SURESCAN $263 5 payments
  11. Other $3,537 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

675

Median for Cardiology: 2,533

Drug cost

$119,090

Median for Cardiology: $485,213

Branded share of claims

22.1%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 79 $90,635
Xarelto Rivaroxaban Brand 20 $16,807
Amiodarone Hcl Generic 141 $3,286
Flecainide Acetate Generic 74 $3,154
Pacerone Amiodarone Hcl Brand 13 $1,146
Metoprolol Succinate Generic 65 $1,127
Bumetanide Generic 19 $587
Warfarin Sodium Generic 49 $551
Sotalol Sotalol Hcl Brand 14 $321
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 11 $294

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$242,934

Medicare's payments for the services billed

Medicare patients

1,952

Average age 77

Services billed

5,186

828 women, 1,124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 67%
Heart failure 56%
Ischemic heart disease 55%
Arthritis 52%
Chronic kidney disease 40%
Diabetes 37%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record